These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20645937)

  • 21. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment.
    Guerra F; Daza JC; Almeda E
    J Investig Allergol Clin Immunol; 2003; 13(2):108-17. PubMed ID: 12968395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
    Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
    Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ; Antvelink JB; Luwema RA
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy.
    Alonso R; Enrique E; Pineda F; Basagaña M; San Miguel-Moncín MM; Bartra J; Palacios R; Cisteró-Bahíma A
    Int Arch Allergy Immunol; 2007; 143(3):185-9. PubMed ID: 17284927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rush sublingual immunotherapy in Parietaria allergic patients.
    D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
    Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early improvement of patients' condition during allergen-specific subcutaneous immunotherapy with a high-dose hypoallergenic 6-grass pollen preparation.
    Rajakulasingam K
    Eur Ann Allergy Clin Immunol; 2012 Jun; 44(3):128-34. PubMed ID: 22905595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis.
    Powell RJ; Frew AJ; Corrigan CJ; Durham SR
    Allergy; 2007 Nov; 62(11):1335-8. PubMed ID: 17714551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublingual immunotherapy.
    Frew AJ
    N Engl J Med; 2008 May; 358(21):2259-64. PubMed ID: 18499568
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients.
    Pfaar O; Sager A; Robinson DS
    Pediatr Allergy Immunol; 2015 May; 26(3):280-286. PubMed ID: 25640879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sublingual specific immunotherapy for rhinoconjunctivitis caused by grass pollens].
    Sabbah A; Lesellin J; Hassoun S; Sicard H; André C
    Allerg Immunol (Paris); 1993 Jun; 25(6):241-7. PubMed ID: 8357473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)].
    Hansen I; Hörmann K; Stuck BA; Schneider-Gêne S; Mösges R; Klimek L
    Laryngorhinootologie; 2003 Aug; 82(8):558-63. PubMed ID: 12915987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR; de Carpentier J
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.